Sign in
4

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001470831-26-000346

Director acquired 4,259 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Anderson Kenneth Carl · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-04-01 Grant or award : show line 1 in the form +4,259 $2.70 $11,499 68,230 D
Loading xslF345X06/wk-form4_1775227552.xml…